These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 11288110

  • 1. Binding of cosalane--a novel highly lipophilic anti-HIV agent--to albumin and glycoprotein.
    Kuchimanchi KR, Ahmed MS, Johnston TP, Mitra AK.
    J Pharm Sci; 2001 May; 90(5):659-66. PubMed ID: 11288110
    [Abstract] [Full Text] [Related]

  • 2. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A, Nishiura T, Ishino M, Yamamoto Y, Ogita I, Kiso Y, Takada K.
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [Abstract] [Full Text] [Related]

  • 3. Transport of cosalane-a highly lipophilic novel anti-HIV agent-across caco-2 cell monolayers.
    Pal D, Udata C, Mitra AK.
    J Pharm Sci; 2000 Jun; 89(6):826-33. PubMed ID: 10824142
    [Abstract] [Full Text] [Related]

  • 4. Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency.
    Cushman M, Insaf S, Paul G, Ruell JA, De Clercq E, Schols D, Pannecouque C, Witvrouw M, Schaeffer CA, Turpin JA, Williamson K, Rice WG.
    J Med Chem; 1999 May 20; 42(10):1767-77. PubMed ID: 10346929
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Disposition of cosalane, a novel anti-HIV agent, in isolated perfused rat livers.
    Udata C, Mitra AK, Badr MZ.
    Drug Metab Dispos; 1999 Aug 20; 27(8):947-50. PubMed ID: 10421624
    [Abstract] [Full Text] [Related]

  • 8. Enhanced transport of a novel anti-HIV agent--cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers.
    Udata C, Patel J, Pal D, Hejchman E, Cushman M, Mitra AK.
    Int J Pharm; 2003 Jan 02; 250(1):157-68. PubMed ID: 12480282
    [Abstract] [Full Text] [Related]

  • 9. Binding of [3H]mianserin to bovine serum albumin, human serum albumin and alpha 1-acid glycoprotein.
    Shami MR, Skellern GG, Whiting B.
    J Pharm Pharmacol; 1984 Jan 02; 36(1):16-20. PubMed ID: 6141257
    [Abstract] [Full Text] [Related]

  • 10. Use of 1-anilino-8-naphthalene sulfonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albumin.
    Essassi D, Zini R, Tillement JP.
    J Pharm Sci; 1990 Jan 02; 79(1):9-13. PubMed ID: 2313585
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of a cosalane analog with an extended polyanionic pharmacophore conferring enhanced potency as an anti-HIV agent.
    Cushman M, Insaf S, Ruell JA, Schaeffer CA, Rice WG.
    Bioorg Med Chem Lett; 1998 Apr 07; 8(7):833-6. PubMed ID: 9871550
    [Abstract] [Full Text] [Related]

  • 12. Cosalane and its analogues: a unique class of anti-HIV agents.
    Zhan P, Li Z, Liu X.
    Mini Rev Med Chem; 2010 Sep 07; 10(10):966-76. PubMed ID: 20540707
    [Abstract] [Full Text] [Related]

  • 13. Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates.
    Paul GC, De Clercq E, Pannecouque C, Witvrouw M, Loftus TL, Turpin JA, Buckheit RW, Cushman M.
    Bioorg Med Chem Lett; 2000 Sep 18; 10(18):2149-52. PubMed ID: 10999491
    [Abstract] [Full Text] [Related]

  • 14. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E, Polnaszek CF, Scheeler DA, Halsall HB, Eckfeldt JH, Holtzman JL.
    J Pharmacol Exp Ther; 1986 Dec 18; 239(3):754-9. PubMed ID: 3795040
    [Abstract] [Full Text] [Related]

  • 15. Correlation of anti-HIV potency with lipophilicity in a series of cosalane analogs having normal alkenyl and phosphodiester chains as cholestane replacements.
    Keyes RF, Golebiewski WM, Cushman M.
    J Med Chem; 1996 Jan 19; 39(2):508-14. PubMed ID: 8558520
    [Abstract] [Full Text] [Related]

  • 16. Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs.
    Finlay GJ, Baguley BC.
    Cancer Chemother Pharmacol; 2000 Jan 19; 45(5):417-22. PubMed ID: 10803926
    [Abstract] [Full Text] [Related]

  • 17. Binding of prazosin to alpha 1-acid glycoprotein and albumin: effect of protein purity and concentrations.
    Sager G, Jaeger R, Little C.
    Pharmacol Toxicol; 1989 Apr 19; 64(4):365-8. PubMed ID: 2748545
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores.
    Santhosh KC, Paul GC, De Clercq E, Pannecouque C, Witvrouw M, Loftus TL, Turpin JA, Buckheit RW, Cushman M.
    J Med Chem; 2001 Mar 01; 44(5):703-14. PubMed ID: 11262081
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics, biliary excretion, and tissue distribution of novel anti-HIV agents, cosalane and dihydrocosalane, in Sprague-Dawley rats.
    Kuchimanchi KR, Udata C, Johnston TP, Mitra AK.
    Drug Metab Dispos; 2000 Apr 01; 28(4):403-8. PubMed ID: 10725308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.